Does genotyping of risk-associated single nucleotide polymorphisms improve patient selection for prostate biopsy when combined with a prostate cancer risk calculator?
出版年份 2013 全文链接
标题
Does genotyping of risk-associated single nucleotide polymorphisms improve patient selection for prostate biopsy when combined with a prostate cancer risk calculator?
作者
关键词
-
出版物
PROSTATE
Volume 74, Issue 4, Pages 365-371
出版商
Wiley
发表日期
2013-11-23
DOI
10.1002/pros.22757
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Predicting prostate biopsy outcome: prostate health index (phi) and prostate cancer antigen 3 (PCA3) are useful biomarkers
- (2012) Matteo Ferro et al. CLINICA CHIMICA ACTA
- Prospective validation of a risk calculator which calculates the probability of a positive prostate biopsy in a contemporary clinical cohort
- (2012) Heidi A. van Vugt et al. EUROPEAN JOURNAL OF CANCER
- Potential Impact of Adding Genetic Markers to Clinical Parameters in Predicting Prostate Biopsy Outcomes in Men Following an Initial Negative Biopsy: Findings from the REDUCE Trial
- (2012) A. Karim Kader et al. EUROPEAN UROLOGY
- Prostate-Specific Antigen (PSA) Isoform p2PSA Significantly Improves the Prediction of Prostate Cancer at Initial Extended Prostate Biopsies in Patients with Total PSA Between 2.0 and 10 ng/ml: Results of a Prospective Study in a Clinical Setting
- (2011) Giorgio Guazzoni et al. EUROPEAN UROLOGY
- Contemporary Role of Prostate Cancer Antigen 3 in the Management of Prostate Cancer
- (2011) Marco Auprich et al. EUROPEAN UROLOGY
- Polygenic Risk Score Improves Prostate Cancer Risk Prediction: Results from the Stockholm-1 Cohort Study
- (2011) Markus Aly et al. EUROPEAN UROLOGY
- Evaluation of Multiple Risk–Associated Single Nucleotide Polymorphisms Versus Prostate-Specific Antigen at Baseline to Predict Prostate Cancer in Unscreened Men
- (2011) Robert J. Klein et al. EUROPEAN UROLOGY
- Characterizing Associations and SNP-Environment Interactions for GWAS-Identified Prostate Cancer Risk Markers—Results from BPC3
- (2011) Sara Lindstrom et al. PLoS One
- EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Treatment of Clinically Localised Disease
- (2010) Axel Heidenreich et al. EUROPEAN UROLOGY
- Upregulation of c-MYC in cis through a Large Chromatin Loop Linked to a Cancer Risk-Associated Single-Nucleotide Polymorphism in Colorectal Cancer Cells
- (2010) J. B. Wright et al. MOLECULAR AND CELLULAR BIOLOGY
- Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers
- (2010) Michael J. Pencina et al. STATISTICS IN MEDICINE
- Replication of the 10q11 and Xp11 Prostate Cancer Risk Variants: Results from a Utah Pedigree-Based Study
- (2009) N. J. Camp et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Genetic Variants and Family History Predict Prostate Cancer Similar to Prostate-Specific Antigen
- (2009) S. L. Zheng et al. CLINICAL CANCER RESEARCH
- Multiple Novel Prostate Cancer Predisposition Loci Confirmed by an International Study: The PRACTICAL Consortium
- (2008) Z. Kote-Jarai et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Chromosome 8q24 markers: Risk of early-onset and familial prostate cancer
- (2008) Jennifer L. Beebe-Dimmer et al. INTERNATIONAL JOURNAL OF CANCER
- Inherited Variation in the Androgen Pathway Is Associated With the Efficacy of Androgen-Deprivation Therapy in Men With Prostate Cancer
- (2008) Robert W. Ross et al. JOURNAL OF CLINICAL ONCOLOGY
- Multiple loci identified in a genome-wide association study of prostate cancer
- (2008) Gilles Thomas et al. NATURE GENETICS
- Multiple newly identified loci associated with prostate cancer susceptibility
- (2008) Rosalind A Eeles et al. NATURE GENETICS
- Cumulative Association of Five Genetic Variants with Prostate Cancer
- (2008) S. Lilly Zheng et al. NEW ENGLAND JOURNAL OF MEDICINE
- A graphical device to represent the outcomes of a logistic regression analysis
- (2008) Ries Kranse et al. PROSTATE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started